Scienture Holdings, Inc. (SCNX)

CIK 0001382574 · Healthcare · Pharma Retailers

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
— 8-K (2026-05-22) · 99.1
Latest Q1-2026 —
FY-2025
Latest FY-2025 —
Q3-2025 —
Q2-2025 —
Q1-2025 —
FY-2024 —
Q3-2024 —
Q2-2024 —
Q1-2024 —
FY-2023
FY-2023 —
Q3-2023 —
Q2-2023 —
FY-2022

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Cover
Statements
Consolidated Balance Sheets
Consolidated Balance Sheets (P)
Consolidated Statements of Operations
Consolidated Statements of Changes In Stockholders' Equity
Consolidated Statements of Cash Flows
Consolidated Statements of Changes In Stockholders' Equity (P)
Notes
Acquisitions and Dispositions
Commitments and Contingencies
Contingencies
Contingent Funding Liabilities
Convertible Debt and Notes Payable
Cybersecurity Risk Management and Strategy Disclosure
—
Debt
—
Disposition of Business
—
Going Concern
Goodwill and Intangible Assets
Income Taxes
—
Insider Trading Arrangements
Intangible Assets
Inventory
Leases
Notes Payable
Notes Receivable
Notes Receivable Related Party
Options
Organization and Basis of Presentation
Other Current Liabilities
Pay Vs Performance Disclosure
Prefunded and Private Placement Warrants
Related Party Transactions
Revenue Recognition
Segment Reporting
Stockholders Equity
Subsequent Events
Warrants